Invest-NL Confirms Robert Schuman as Permanent Director of Venture Capital
Amsterdam, Monday 26 January 2026
Robert Schuman permanently assumes the helm of Invest-NL’s venture capital arm, leveraging extensive corporate finance experience to accelerate funding for the Netherlands’ critical deep tech and sustainability transitions.
Strategic Leadership for a Evolving Market
The confirmation of Robert Schuman as the permanent Director of Venture Capital marks a decisive step for Invest-NL as it navigates a maturing investment landscape. Schuman, who has served as Director of Capital ad interim since March 2025, brings a multifaceted history in finance and governance to the state-backed fund [1][3]. His career spans a tenure as Director at NIB Capital from 1993 to 2002, the founding of advisory firm Nielen Schuman, and a role as CFO at G-Star starting in 2011 [1]. Crucially, his experience as a co-founder of Health Investment Partners since 2016 aligns with Invest-NL’s increasing focus on impact investing in complex sectors [1]. CEO Rinke Zonneveld noted that Schuman’s emphasis on “investing, managing, and learning” has already provided a solid contribution to the organisation’s standing over the past year [3].
Navigating the 2026 Venture Landscape
Schuman takes the reins at a time when the Dutch venture capital market is demonstrating significant resilience. Following a robust period where investment in Dutch startups increased by 67% in the second quarter of 2025 compared to the previous year, the market in 2026 is characterised by a selective, sector-driven approach [4]. Artificial Intelligence (AI) and deep tech currently lead funding lists in both the Netherlands and Europe, with climate tech and healthtech following closely [4]. This shifts the operational imperative for Invest-NL from merely providing capital to strategically supporting high-complexity technologies that require patient capital to scale.
Deep Tech and Digital Infrastructure
The fund’s recent activity underscores the critical importance of deep tech and the digitalisation of infrastructure. Dutch AI companies have been raising Series A and B rounds ranging from €10 million to over €50 million throughout 2025 and early 2026 [4]. Invest-NL has actively participated in this high-tech surge; notably, the fund’s Deep Tech Fund recently invested €10 million in Qualinx B.V. [2]. This scale-up is developing energy-efficient GNSS chips, a strategic semiconductor technology that enhances European technological autonomy and contributes to sustainable digital infrastructure [2]. Such investments reflect a broader trend where deep-tech breakthroughs are driving the largest funding rounds in the country, with some mega-deals reaching up to €430 million [4].
Healthtech and Sustainable Transitions
Schuman’s background in health impact investing is particularly pertinent as the sector undergoes rapid digitalisation. In 2025 alone, Dutch healthtech companies raised approximately €162 million, with a significant portion of global funding flowing toward AI-driven solutions [4]. Invest-NL has continued to support this ecosystem, evidenced by its investment in ShanX Medtech BV, an Eindhoven-based startup developing diagnostic systems to determine effective antibiotics, thereby improving patient care and managing healthcare costs [2]. Beyond healthcare, the fund is aggressively financing the energy transition. This includes a €100 million project financing deal for Fastned to realise 70 new fast-charging locations across Belgium and Switzerland, and a €10 million investment in PureTerra Ventures Fund II to scale innovative water technologies [2].